Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.
about
Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.From leeches to personalized medicine: evolving concepts in the management of polycythemia vera.Detection of driver and subclonal mutations in myelofibrosis: clinical impact on pharmacologic and transplant based treatment strategies.The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis.Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis.Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosisApplication of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis.Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.Driver mutations' effect in secondary myelofibrosis: an international multicenter study based on 781 patients.Benefits and pitfalls of Peg-Interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis, a French Intergroup of Myeloproliferative neoplasms (FIM) study.
P2860
Q33442613-710A6F23-F77E-4D1C-809F-289955EEAE45Q37555790-D2B708D5-F971-47CB-8059-704AA5418780Q38786380-AEE0CCD1-4310-445A-BEC2-B5B63003DC6DQ40197045-E5B0DF33-2BD2-4CA0-8337-0892CEA807ADQ42355923-267D9A75-9C99-4C03-9EF5-925AABA9D0F9Q42388540-6FC7B1D2-57FE-47A3-AA8C-3EA4C52F97DEQ47147199-6BD8E508-2E6D-457F-A901-F93D5C5E628BQ47209528-9F816726-ECF8-4E61-9F16-06D57064A270Q48735434-F48992DD-73FD-4CD2-968D-2781E5E6AA8CQ50020976-D258A8CB-4745-4240-8BCB-0AB9630B516B
P2860
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Epidemiology and clinical rele ...... 9 patients of the AGIMM group.
@en
Epidemiology and clinical rele ...... 9 patients of the AGIMM group.
@nl
type
label
Epidemiology and clinical rele ...... 9 patients of the AGIMM group.
@en
Epidemiology and clinical rele ...... 9 patients of the AGIMM group.
@nl
prefLabel
Epidemiology and clinical rele ...... 9 patients of the AGIMM group.
@en
Epidemiology and clinical rele ...... 9 patients of the AGIMM group.
@nl
P2093
P2860
P50
P356
P1476
Epidemiology and clinical rele ...... 9 patients of the AGIMM group.
@en
P2093
Alessandro M Vannucchi
Alessandro Rambaldi
Annalisa Pacilli
Clara Belotti
Daniela Cilloni
Elisa Rumi
Emanuela Sant'Antonio
Giada Brogi
Giada Rotunno
Isabella Bernardis
P2860
P304
P356
10.1002/AJH.24377
P50
P577
2016-04-02T00:00:00Z